Atlas Trials

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

Clinical trial NCT06866977 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06866977
Sponsor
Xiangya Hospital of Central South University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2025-03-12
Primary completion
2025-10-31
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.